Vertex Pharmaceuticals (VRTX) EBITDA Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1,536.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -957.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 8,807.00 |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,536.00 |
| Dec 31, 2025 | 257.00 |
| Sep 30, 2025 | -171.00 |
| Jun 30, 2025 | 17,168.00 |
| Mar 31, 2025 | -1,961.00 |
| Dec 31, 2024 | -403.00 |
| Sep 30, 2024 | -153.00 |
| Jun 30, 2024 | -17,402.00 |
| Mar 31, 2024 | 955.00 |
| Dec 31, 2023 | -562.00 |
| Sep 30, 2023 | -647.00 |
| Jun 30, 2023 | -921.00 |
| Mar 31, 2023 | -1,682.00 |
| Dec 31, 2022 | 253.00 |
| Sep 30, 2022 | -488.00 |
| Jun 30, 2022 | 5,249.00 |
| Mar 31, 2022 | -186.00 |
| Dec 31, 2021 | -347.00 |
| Sep 30, 2021 | 945.00 |
| Jun 30, 2021 | -4,921.00 |
| Mar 31, 2021 | 395.00 |
| Dec 31, 2020 | -30,814.00 |
| Sep 30, 2020 | 3,324.00 |
| Jun 30, 2020 | 1,842.00 |
| Mar 31, 2020 | 1,529.00 |
| Dec 31, 2019 | 33,928.00 |
| Sep 30, 2019 | -1,575.00 |
| Jun 30, 2019 | 570.00 |
| Mar 31, 2019 | 1,213.00 |
| Dec 31, 2018 | -462.00 |
| Sep 30, 2018 | 8,261.00 |
| Jun 30, 2018 | 1,330.00 |
| Mar 31, 2018 | -1,778.00 |
| Dec 31, 2017 | 1,065.00 |
| Sep 30, 2017 | -5,182.00 |
| Jun 30, 2017 | 890.00 |
| Mar 31, 2017 | 4,149.00 |
| Dec 31, 2016 | 2,185.00 |
| Sep 30, 2016 | 1,858.00 |
| Jun 30, 2016 | 10,385.00 |